Graduate Students

Class of 2014

EUGENE KREYS, PHARM.D., PH.D. CANDIDATEEUGENE KREYS, PHARM.D., PH.D. CANDIDATE
Major Professor: Jim Koeller, M.S.


KELLY REVELES, PHARM.D., PH.D.KELLY REVELES, PHARM.D., PH.D. CANDIDATE
Major Professor: Christopher R. Frei, Pharm.D., M.S., BCPS, FCCP


BESU TESHOME, PHARM.D., M.S. CANDIDATEBESU TESHOME, PHARM.D., M.S. CANDIDATE
Major Professor: Christopher R. Frei, Pharm.D., M.S., BCPS, FCCP


Class of 2013

IVAN REVELES, PHARM.D., M.S., BCPSIVAN REVELES, PHARM.D., M.S., BCPS
Segmented and Total Direct Cost of Care for Advanced Squamous Cell Carcinoma of the Head and Neck in a Privately Insured PopulationMajor Professor: Jim Koeller, M.S

Supervising Committee Members:

Christopher R. Frei, Pharm.D., M.S., BCPS, FCCP


AMBER SMITH, PHARM.D., M.S., BCPSAMBER SMITH, PHARM.D., M.S., BCPS
Spironolactone to treat hypertension in ESRD: an analysis of effectiveness and safety

Major Professor: Jim Koeller, M.S.

Supervising Committee Members:Chris Martin, Pharm.D., M.S.
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE
Jennifer Seltzer, Pharm.D.


Class of 2012

MATTHEW LABRECHE, PHARM.D., M.S., BCPS
Oral antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs) in the primary care setting: incidence of treatment failure and its additional economic impact

Major Professor: Christopher R. Frei, Pharm.D., M.S., BCPS, FCCP

Supervising Committee Members:Jim Koeller, M.S.
Russell Attridge, Pharm.D., M.S., BCPS


AASYA NASAR, PHARM.D., M.S., BCPS
Influence of serum and albumin on echinocandin pharmacodynamics

Major Professor: Nathan P. Wiederhold, Pharm.D., FCCP

Supervising Committee Members:

Christopher R. Frei, Pharm.D., M.S., BCPS, FCCP
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE
Jason Cota, Pharm.D., M.S., BCPS


Class of 2011

ALLISON BELL, PHARM.D., M.S., BCPSALLISON BELL, PHARM.D., M.S., BCPS
Total and Segmented Direct Cost-of-Care for Stage IV Non-Small Cell Lung Cancer in a Privately Insured Population Major Professor: Jim M. Koeller, M.S.

Supervising Committee Members:

Christopher R. Frei, Pharm.D., M.S., BCPS
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE
John Penrod


NICHOLAS FORCADE, PHARM.D., M.S., BCPSNICHOLAS FORCADE, PHARM.D., M.S., BCPS
Prevalence, Severity, and Treatment of CA-MRSA Skin and Soft Tissue Infections in Outpatient Clinics in TexasMajor Professor: Christopher R. Frei, Pharm.D., M.S., BCPS

Supervising Committee Members:

Robert L. Talbert, Pharm.D., BCPS, FCCP
Nathan P. Wiederhold, Pharm.D.
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE


CHRISTINE U. ORAMASIONWU, PHARM.D., M.S., BCPSCHRISTINE ORMASIONWU, PHARM.D., PH.D., BCPS
Health disparities between blacks and whites with HIV/AIDS: an analysis of U.S. national health care surveys from 1996-2008Major Professor: Christopher R. Frei, Pharm.D., M.S., BCPS, FCCP

Supervising Committee Members:

Jim Koeller, M.S.
Carolyn Brown, Ph.D.
Kenneth Lawson, Ph.D.
Gene D. Morse, Pharm.D., FCCP


Class of 2010

RUSSELL T. ATTRIDGE, PHARM.D., M.S., BCPSRUSSELL T. ATTRIDGE, PHARM.D., M.S., BCPS
Guideline-Concordant Antibiotic Therapy Is Not Associated with Improved Outcomes in Healthcare-Associated PneumoniaMajor Professor: Christopher R. Frei, Pharm.D., M.S., BCPS

Supervising Committee Members:

Kenneth A. Lawson, Ph.D.
Eric M. Mortensen, M.D., M.S., FACP
Marcos I. Restrepo, M.D., M.S.
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE


JASON M. COTA, PHARM.D., M.S., BCPSANDRES D RUIZ, PHARM.D., M.S.
Bioidentical Hormone Replacement Therapy: Evaluating the Safety and EffectivenessMajor Professor: Christopher R. Frei, Pharm.D., M.S., BCPS

Supervising Committee Members:

Jamie Barner, Ph.D., R.Ph.
Jeff Carson, B.S. Pharm., R.Ph.


OLAONIPEKUN OYETAYO, PHARM.D., M.S., BCPSOLAONIPEKUN OYETAYO, PHARM.D., M.S., BCPS
Effects of Interaction between Proton Pump Inhibitors and Clopidogrel on Clinical OutcomesMajor Professor: Robert L. Talbert, Pharm.D., BCPS

Supervising Committee Members:

Steven R. Bailey, M.D., FSCAI, FACC
Christopher R. Frei, Pharm.D., M.S., BCPS
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE


WARUNEE SRISUPA-OLARN, PHARM.D., M.S., BCPSWARUNEE SRISUPA-OLARN, PHARM.D., M.S., BCPS
Colistin for Multi-drug Resistant Acinetobacter baumanii from ThailandMajor Professor: David S. Burgess, Pharm.D., FCCP

Supervising Committee Members:

Christopher R Frei, Pharm.D., M.S., BCPS
Y.W. Francis Lam, Pharm.D., FCCP


Class of 2009

CHRISTINE U. ORAMASIONWU, PHARM.D., M.S., BCPSCHRISTINE U. ORAMASIONWU, PHARM.D., M.S., BCPS
Disparities in Antiretroviral Prescribing Patterns and Health Outcomes between Black and White HIV / AIDS Patients: An Analysis of U.S. National Health Care Surveys from 1996-2006**Outstanding UT Austin Master’s Thesis/Report Winner**

Major Professor: Christopher R. Frei, Pharm.D., M.S., BCPS

Supervising Committee Members:

Carolyn M. Brown, Ph.D.
Kenneth A. Lawson, Ph.D.
Alice K. Pau, Pharm.D.
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE


REBECCA L. OWENS, PHARM.D., M.S., BCPSREBECCA L. OWENS, PHARM.D., M.S., BCPS
Evaluation of the Incidence and Risk Factors for Development of Fenofibrate-Associated NephrotoxicityMajor Professor: Jim M. Koeller, M.S.

Supervising Committee Members:

Christopher R. Frei, Pharm.D., M.S., BCPS
William D. Linn, Pharm.D.
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE


REBECCA D. MOOTE, PHARM.D., M.S., BCPSREBECCA D. MOOTE, PHARM.D., M.S., BCPS
Platelet Response to Aspirin in Healthy VolunteersMajor Professor: Robert L. Talbert, Pharm.D., BCPS, FCCP

Supervising Committee Members:

Christopher R. Frei, Pharm.D., M.S., BCPS
Laurajo Ryan, Pharm.D., M.S., BCPS, CDE


Class of 2008

MONICA L. MILLER, PHARM.D., M.S., BCPSMONICA L. MILLER, PHARM.D., M.S., BCPS
Health and Economic Outcomes of Vancomycin Alternatives as Treatment Options for Methicillin Resistant Staphylococcus aureus Skin InfectionsMajor Professor: Christopher R. Frei, Pharm.D., M.S., BCPS

Supervising Committee Members:Kenneth A. Lawson, Ph.D.
James S. Lewis, Pharm.D.


LAN-PHUONG (ASHLEY) PHAM TRAN, PHARM.D., M.S., BCPS, BCOPLAN-PHUONG (ASHLEY) PHAM TRAN, PHARM.D., M.S., BCPS, BCOP
Evaluation of RAF Kinase Polymorphisms in HER2-Positive Breast Cancer PatientsMajor Professor: Jodi L. Grabinski, Pharm.D., M.S., BCOP

Supervising Committee Members:

John G. Kuhn, Pharm.D., BCOP, FCCP
Carla Van Den Berg, Pharm.D.
Muralidhar Beeram, M.D., MBBS


Class of 2007

JASON M. COTA, PHARM.D., M.S., BCPSJASON M. COTA, PHARM.D., M.S., BCPS
Compensatory Response of the Cell Wall Integrity Pathway and Chitin to Caspofungin Exposure in Candida glabrataMajor Professor: Nathan P. Wiederhold, Pharm.D.

Supervising Committee Members:David S. Burgess, Pharm.D., FCCP
Jodi L. Grabinski, Pharm.D., M.S., BCOP
Jose Lopez-Ribot, Ph.D
Robert L. Talbert, Pharm.D., BCPS, FCCP


TREVOR MCKIBBIN, PHARM.D., M.S., BCPSTREVOR MCKIBBIN, PHARM.D., M.S., BCPS
Impact of Age on the Chemotherapy Treatment and Outcomes of Advanced Colorectal Cancer in the Community Oncology SettingMajor Professor: Jim M. Koeller, M.S.

Supervising Committee Members:Christopher R. Frei, Pharm.D., M.S., BCPS
-Rebecca E. Greene, Pharm.D., BCOP


Class of 2006

CARLOS A. ALVAREZ, PHARM.D., M.S., BCPSCARLOS A. ALVAREZ, PHARM.D., M.S., BCPS
Aerosolized Nanoparticles of Itraconazole for the Prevention of Invasive Pulmonary Aspergillosis due to Aspergillus fumigatus in a Murine ModelMajor Professor: Nathan P. Wiederhold, Pharm.D.

Supervising Committee Members:David S. Burgess, Pharm.D., FCCP
Jay I. Peters, M.D.
Robert L. Talbert, Pharm.D., BCPS, FCCP
Robert O. Williams, Ph.D.


Class of 2005

BARBARA J. HOEBEN, PHARM.D., M.S.BARBARA J. HOEBEN, PHARM.D., M.S.
Comparison of Commercial Itraconazole to Aerosolized Nanoparticle Itraconazole in a Murine Model for the Prevention of Invasive Pulmonary Aspergillosis

** Outstanding UT Austin Master’s Thesis/Report Winner**

Major Professors:

David S. Burgess. Pharm.D., FCCP
Robert L. Talbert, Pharm.D., BCPS, FCCP
Supervising Committee Members:
Jay L. Peters, M.D.
Robert O. Williams, Ph.D.


 

TROY A. MOORE, PHARM.D., M.S., BCPPTROY A. MOORE, PHARM.D., M.S., BCPP
Antidepressant Medication Management in Depression Patients: A Role for Clinical PharmacistsMajor Professor: Jim M. Koeller, M.S.

Supervising Committee Members:Cynthia A. Mascarenas, Pharm.D., M.S., BCPP
Christopher R. Frei, Pharm.D., M.S., BCPS
Iva M. Timmerman, M.D.


SHANNON N. SALDANA, PHARM.D., M.S., BCPPSHANNON N. SALDANA, PHARM.D., M.S., BCPP
Genetic Analysis in the Relationship between Brain-Derived Neurotropic Factor and SchizophreniaMajor Professor: Stephen R. Saklad, Pharm.D., BCPP

Supervising Committee Members:Michael Escamilla, M.D.
Jody Grabinski, Pharm.D, M.S., BCOP
Cindy Mascarenas, Pharm.D., M.S,, BCPP


CHRISTOPHER P. MARTIN, PHARM.D., M.S., BCPSCHRISTOPHER P. MARTIN, PHARM.D., M.S., BCPS
A Clinical and Laboratory Evaluation of the Efficacy of HMG-CoA Reductase Inhibitors in SepsisMajor Professor :Robert L. Talbert, Pharm.D., BCPS, FCCP

Supervising Committee Members:

David S. Burgess, Pharm.D., FCCP
Jay I. Peters, M.D.


 

DOUGLAS L. BOGGS, PHARM.D., M.S., BCPPDOUGLAS L. BOGGS, PHARM.D., M.S., BCPP
The Effect of Second Generation Antipsychotics on Weight Gain in Children and AdolescentsMajor Professor: Stephen R. Saklad, Pharm.D., BCPP

Supervising Committee Members:M. Lynn Crismon, Pharm.D., BCPP, FCCP
Jerry G. Olsen, M.D.
Robert L. Talbert, Pharm.D., BCPS, FCCP


Class of 2004

ALICIA M. REESE, PHARM.D., M.S., BCPSALICIA M. REESE, PHARM.D., M.S., BCPS
In Vitro Activity and Pharmacodynamics of Tigecycline Against Gram-Negative Organisms** Outstanding UT Austin Master’s Thesis/Report Winner**
Major Professor: David S. Burgess, Pharm.D., FCCP

Supervising Committee Members:James H. Jorgensen, Ph.D.
Robert L. Talbert, Pharm.D., BCPS, FCCP


Class of 2003

CHRISTI M. LOPEZ, PHARM.D., M.S.CHRISTI M. LOPEZ, PHARM.D., M.S.
Incidence of antihyperglycemic medication use following atypical antipsychotic use in a Texas medicaid population

Major Professor: Leroy Knodel, Pharm.D.

Supervising Committee Members:Karen Rascati, Ph.D,
Robert Talbert, Pharm.D., BCPS, FCCP
Veronica Young, Pharm.D.


BRADI L. JONES, PHARM.D., M.S., BCPS, BCOP

BRADI L. JONES, PHARM.D., M.S., BCPS, BCOP
Investigation of Pulmonary and Oral Delivery of Itraconazole Produced by Evaporative Precipitation into Aqueous Solution (EPAS) and Spray-Freezing into Liquid (SFL) Technology in a Murine Model

**Outstanding UT Austin Master’s Thesis/Report Winner**

Major Professor: Robert L. Talbert, Pharm.D, BCPS, FCCP

Supervising Committee Members:David S. Burgess, Pharm.D., FCCP
Jay I. Peters, M.D.
Robert O. Williams, Ph.D.


CYNTHIA A. MASCARENAS, PHARM.D., M.S., BCPS, BCPPCYNTHIA A. MASCARENAS, PHARM.D., M.S., BCPS, BCPP
Evaluation of the Clinical Drug Interaction Potential of Citalopram Compared to Paroxetine and Fluoxetine on CYP2D6 using Dextromethorphan Probe Technology

Major Professor:Larry Ereshefsky, Pharm.D., BCPP

Supervising Committee MembersDavid S. Burgess, Pharm.D.
Y. W. Francis Lam, Pharm.D.
Stephen R. Saklad, Pharm.D., BCPP


CHRISTOPHER R. FREI, PHARM.D., M.S., BCPS, FCCPCHRISTOPHER R. FREI, PHARM.D., M.S., BCPS, FCCP
Impact of Antimicrobial Therapy on Outcomes in Hospitalized Patients with Community-Acquired Pneumonia

Major Professor: Jim M. Koeller, M.S.

Supervising Committee Members:David S. Burgess, Pharm.D., FCCP
Michael T. Johnsrud, Ph.D.
Robert L. Talbert, Pharm.D., BCPS, FCCP


Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy